Barriers to influenza vaccination among pregnant women

Eppes, Catherine; Wu, Alison; You, Whitney; Cameron, Kenzie A.; Garcia, Patrícia Azevedo; Grobman, William A.

doi:10.1016/j.vaccine.2013.04.031

Cited by 70 publications

(81 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…28,29,[34][35][36][37][38][39][40][41] Most women identified safety concerns such as side effects as the greatest barrier to immunization during pregnancy. [29][30][31][32][35][36][37][38]42,43,45,46 While women were concerned about their own safety 25,30,34,37,[44][45][46]51,52 or prior adverse events with the vaccine, 46,47 safety concerns for the fetus and newborn were paramount. 22,25,30,31,34,39,[44][45][46]51,52 Doubt about the effectiveness of the vaccine was particularly noted with influenza vaccine.…”

Section: Factors Related To Pregnant Womenmentioning

confidence: 99%

“…22,25,30,31,34,39,[44][45][46]51,52 Doubt about the effectiveness of the vaccine was particularly noted with influenza vaccine. 22,25,32,34,35 General mistrust of vaccinations 37 was mentioned in studies related to influenza, 29 pertussis, 30 and group B Streptococcus. 49 In some women, fear of needles presented a barrier to any immunization, including those given during pregnancy.…”

Section: Factors Related To Pregnant Womenmentioning

confidence: 99%

See 1 more Smart Citation

Improving rates of maternal immunization: Challenges and opportunities

MacDougall

Halperin

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Objectives: An increasing number of vaccines are recommended or are being developed for use during pregnancy to protect women, fetuses, and/or newborns. For vaccines that are already recommended, vaccine uptake is variable and well below desired target. We reviewed the literature related to factors that affect a healthcare provider's recommendation and a woman's willingness to be vaccinated during pregnancy. Design: A scoping review of published literature from 2005 to 2015 was undertaken and all relevant articles were abstracted, summarized, and organized thematically. Results: Barriers and facilitators were identified that either decreased or increased the likelihood of a healthcare provider offering and a pregnant woman accepting vaccination during pregnancy. Concern about the safety of vaccines given during pregnancy was the most often cited barrier among both the public and healthcare providers. Other barriers included doubt about the effectiveness of the vaccine, lack of knowledge about the burden of disease, and not feeling oneself to be at risk of the infection. Major facilitators for maternal immunization included specific safety information about the vaccine in pregnant women, strong national recommendations, and healthcare providers who both recommended and provided the vaccine to their patients. Systems barriers such as inadequate facilities and staffing, vaccine purchase and storage, and reimbursement for vaccination were also cited. Evidence-based interventions were few, and included text messaging reminders, chart reminders, and standing orders. Conclusions: In order to have an effective vaccination program, improvements in the uptake of recommended vaccines during pregnancy are needed. A maternal immunization platform is required that normalizes vaccination practice among obstetrical care providers and is supported by basic and continuing education, communication strategy, and a broad range of research.

show abstract

Section: Factors Related To Pregnant Womenmentioning

confidence: 99%

Section: Factors Related To Pregnant Womenmentioning

confidence: 99%

Improving rates of maternal immunization: Challenges and opportunities

MacDougall

Halperin

2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

“…This increase in discourse about the vaccine between women and their providers is a significant finding given that health care provider recommendation has emerged repeatedly in the literature as a key factor contributing to acceptance of vaccine by pregnant women. 20,25 Schindler et al 26 describe a zone of indecision, a gray zone, between 2 nuanced positions, which manifest in hesitancy in decision making. The more positive and committed toward vaccination, the more likely the health care provider is to promote the vaccine with his pregnant patients.…”

Section: Discussionmentioning

confidence: 99%

Maintaining the momentum: Key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic

Halperin

MacKinnon‐Cameron

McNeil

et al. 2014

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

“…81,82 False beliefs about influenza susceptibility and severity and the effectiveness of vaccination have been associated with reduced maternal uptake of the vaccine. 83 Similarly many pregnant women may be unaware of their risk of acquiring and then exposing their infant to pertussis, an infant's increased susceptibility to pertussis, and the consequences of neonatal pertussis. 84 Perceived susceptibility to disease and accurate understanding of the disproportionate severity of influenza disease in pregnancy and pertussis in neonates appear to be necessary precedents to acceptance of vaccination in pregnancy.…”

Section: Lack Of Perceived Susceptibility and Misinformation About Vamentioning

confidence: 99%